Are results from VARSITY applicable to real world? Adalimumab versus vedolizumab as first line biological in moderate-to-severe IBD

被引：0
|
作者：
Moens, A. [1 ,2 ]
Verstockt, B. [1 ,2 ]
Alsoud, D. [2 ]
Sabino, J. [1 ,2 ]
Ferrante, M. [1 ,2 ]
Vermeire, S. [1 ,2 ]
机构：
[1] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.433
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P309
引用
收藏
页码：S336 / S337
页数：4
相关论文
共 50 条
  • [31] Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)
    Cichoz-Lach, Halina
    Michalak, Agata
    Kopertowska-Majchrzak, Maria
    Eder, Piotr
    Stawczyk-Eder, Kamila
    Waszak, Katarzyna
    Talar-Wojnarowska, Renata
    Zatorski, Hubert
    Solarska-Polchlopek, Anna
    Chmielnicki, Jaroslaw
    Filip, Rafal
    Pekala, Anna
    Janiak, Maria
    Skrobot, Krzysztof
    Kasinska, Ewa
    Krogulecki, Michal
    Krolikowski, Piotr
    Klopocka, Maria
    Liebert, Ariel
    Poniewierka, Elzbieta
    Smola, Izabela
    Gasiorowska, Anita
    Kaczka, Aleksandra
    Wypych, Joanna
    Wojciechowski, Krzysztof
    Drygala, Szymon
    Zagorowicz, Edyta
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [32] Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
    Li, Gaojie
    Gu, Yuanxia
    Zou, Qin
    Wang, Yiyi
    Xiao, Yue
    Xia, Dengmei
    Zhan, Tongying
    Zhou, Xingli
    Wang, Qian
    Yan, Wei
    Li, Wei
    DERMATOLOGY AND THERAPY, 2022, 12 (09) : 2105 - 2115
  • [33] Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
    Talat Bessissow
    Geoffrey C Nguyen
    Osman Tarabain
    Laurent Peyrin-Biroulet
    Nathalie Foucault
    Kevin Mc Hugh
    Joannie Ruel
    World Journal of Gastroenterology, 2022, 28 (34) : 5058 - 5075
  • [34] The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis: a UK prospective, multicenter, observational study
    Leman, Joyce
    Walton, Shernaz
    Layton, Alison M.
    Ward, Kathleen A.
    McBride, Sandy
    Cliff, Sandeep
    Downs, Anthony
    Landeira, Margarita
    Bewley, Anthony
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (03) : 213 - 221
  • [35] Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
    Bessissow, Talat
    Nguyen, Geoffrey C.
    Tarabain, Osman
    Peyrin-Biroulet, Laurent
    Foucault, Nathalie
    McHugh, Kevin
    Ruel, Joannie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (34) : 5058 - 5075
  • [36] Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
    Gaojie Li
    Yuanxia Gu
    Qin Zou
    Yiyi Wang
    Yue Xiao
    Dengmei Xia
    Tongying Zhan
    Xingli Zhou
    Qian Wang
    Wei Yan
    Wei Li
    Dermatology and Therapy, 2022, 12 : 2105 - 2115
  • [37] Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
    Colombel, Jean-Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    Kamm, Michael A.
    Yu, Andrew P.
    Wu, Eric Q.
    Pollack, Paul F.
    Lomax, Kathleen G.
    Chao, Jingdong
    Mulani, Parvez M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (05): : 1170 - 1179
  • [38] TRANSCRIPTOMIC SIGNATURE OF RESPONSE TO VEDOLIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM AN INTERNATIONAL, MULTICENTER, RETROSPECTIVE COHORT STUDY
    Linggi, Bryan
    Salas, Azucena
    Veny, Marisol
    Borowski, Krzysztof
    Silverberg, Mark S.
    Milgrom, Raquel
    Stempak, Joanne
    Boland, Brigid
    Eckmann, Lars
    Smith, Michelle I.
    Parker, Claire E.
    Jairath, Vipul
    Teft, Wendy
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2024, 166 (05) : S1114 - S1114
  • [39] REAL-WORLD DISCONTINUATION OF BIOLOGICAL TREATMENTS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS OVER THE FIRST 5 YEARS OF TREATMENT - A LITERATURE REVIEW OF DRUG SURVIVAL
    Apol, E.
    Ziegler, F.
    Egeberg, A.
    VALUE IN HEALTH, 2018, 21 : S440 - S440
  • [40] Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective cohort study
    Linggi, B.
    Salas, A.
    Veny, M.
    Borowski, K.
    Silverberg, M. S.
    Milgrom, R.
    Stempak, J.
    Boland, B.
    Eckmann, L.
    Smith, M. I.
    Parker, C. E.
    Jairath, V.
    Teft, W.
    Vande Casteele, N.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I71 - I71
12345